Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Arca

Showing results (161-170 of 212) with videos related to

Pageof 22
Sort By:
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 16, 2023
Consensus document on Lipoprotein(a) from the Italian Society for the Study of Atherosclerosis (SISA)Giulia Chiesa, Maria Grazia Zenti, Andrea Baragetti, et al.
Frontiers in Immunology|February 16, 2026
Case Report: Extracorporeal photopheresis for cutaneous lupus erythematosus induces putatively atheroprotective B and T cell responsesMarcella Visentini, Maria Ozsvar-Kozma, Ilenia Pacella, et al.
Journal of Clinical Lipidology|July 26, 2025
Patient experience with familial chylomicronemia syndrome before and after olezarsen treatment: Qualitative interviews with clinical trial participantsAsia Sikora Kessler, T Michelle Brown, Emily Bratlee-Whitaker, et al.
Biochemical and Biophysical Research Communications|March 15, 2008
Clinical and genetic characterization of Chanarin-Dorfman syndromeClaudio Bruno, Enrico Bertini, Maja Di Rocco, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|March 11, 2020
ANGPTL3 deficiency alters the lipid profile and metabolism of cultured hepatocytes and human lipoproteinsHanna Ruhanen, P A Nidhina Haridas, Ilenia Minicocci, et al.
Journal of Clinical Lipidology|May 12, 2018
Clinical and biochemical features of different molecular etiologies of familial chylomicronemiaRobert A Hegele, Amanda J Berberich, Matthew R Ban, et al.
International Journal of Cardiology|June 1, 2013
Functional and morphological vascular changes in subjects with familial combined hypolipidemia: an exploratory analysisIlenia Minicocci, Vito Cantisani, Eleonora Poggiogalle, et al.
Scientific Reports|March 1, 2018
Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing StrategyAlessia Di Costanzo, Francesca Belardinilli, Diego Bailetti, et al.
Journal of Clinical Lipidology|December 2, 2025
Long-term efficacy and safety of lomitapide in patients with familial chylomicronemia syndrome: Data from an expanded access programAntonina Giammanco, Laura D'Erasmo, Gabriella Iannuzzo, et al.
Journal of Internal Medicine|June 11, 2026
Angiopoietin-like protein 3 complete and partial deficiency markedly accelerates apolipoprotein B48 and B100 metabolism in triglyceride-rich lipoproteins in humansMarcello Arca, Elias Björnson, Laura D'Erasmo, et al.
Pageof 22

Showing results (161-170 of 212) with videos related to

Sort By:
Pageof 22
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 16, 2023
Consensus document on Lipoprotein(a) from the Italian Society for the Study of Atherosclerosis (SISA)Giulia Chiesa, Maria Grazia Zenti, Andrea Baragetti, et al.
Frontiers in Immunology|February 16, 2026
Case Report: Extracorporeal photopheresis for cutaneous lupus erythematosus induces putatively atheroprotective B and T cell responsesMarcella Visentini, Maria Ozsvar-Kozma, Ilenia Pacella, et al.
Journal of Clinical Lipidology|July 26, 2025
Patient experience with familial chylomicronemia syndrome before and after olezarsen treatment: Qualitative interviews with clinical trial participantsAsia Sikora Kessler, T Michelle Brown, Emily Bratlee-Whitaker, et al.
Biochemical and Biophysical Research Communications|March 15, 2008
Clinical and genetic characterization of Chanarin-Dorfman syndromeClaudio Bruno, Enrico Bertini, Maja Di Rocco, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|March 11, 2020
ANGPTL3 deficiency alters the lipid profile and metabolism of cultured hepatocytes and human lipoproteinsHanna Ruhanen, P A Nidhina Haridas, Ilenia Minicocci, et al.
Journal of Clinical Lipidology|May 12, 2018
Clinical and biochemical features of different molecular etiologies of familial chylomicronemiaRobert A Hegele, Amanda J Berberich, Matthew R Ban, et al.
International Journal of Cardiology|June 1, 2013
Functional and morphological vascular changes in subjects with familial combined hypolipidemia: an exploratory analysisIlenia Minicocci, Vito Cantisani, Eleonora Poggiogalle, et al.
Scientific Reports|March 1, 2018
Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing StrategyAlessia Di Costanzo, Francesca Belardinilli, Diego Bailetti, et al.
Journal of Clinical Lipidology|December 2, 2025
Long-term efficacy and safety of lomitapide in patients with familial chylomicronemia syndrome: Data from an expanded access programAntonina Giammanco, Laura D'Erasmo, Gabriella Iannuzzo, et al.
Journal of Internal Medicine|June 11, 2026
Angiopoietin-like protein 3 complete and partial deficiency markedly accelerates apolipoprotein B48 and B100 metabolism in triglyceride-rich lipoproteins in humansMarcello Arca, Elias Björnson, Laura D'Erasmo, et al.
Pageof 22